n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine has been researched along with Myocardial Ischemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, MV; Downey, JM; Garlid, KD; Grover, GJ; Krieg, T; Oldenburg, O; Yang, XM | 1 |
Antonaccio, MJ; Dzwonczyk, S; Grover, GJ; Normandin, D; Sargent, CA; Sleph, PG | 1 |
Marbán, E; O'Rourke, B; Sasaki, N; Sato, T; Seharaseyon, J | 1 |
3 other study(ies) available for n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine and Myocardial Ischemia
Article | Year |
---|---|
P1075 opens mitochondrial K(ATP) channels and generates reactive oxygen species resulting in cardioprotection of rabbit hearts.
Topics: Animals; Brain Chemistry; Decanoic Acids; Diazoxide; Glyburide; Guanidines; Hydroxy Acids; Ischemic Preconditioning, Myocardial; Liposomes; Mitochondria, Heart; Myocardial Infarction; Myocardial Ischemia; Potassium Channels; Pyridines; Rabbits; Rats; Reactive Oxygen Species; Vasodilator Agents | 2003 |
Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075.
Topics: Animals; Aorta, Thoracic; Coronary Circulation; Dose-Response Relationship, Drug; Guanidines; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Potassium Channels; Pyridines; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Vasodilator Agents; Ventricular Function, Left | 1993 |
Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection.
Topics: Adenosine Triphosphate; Animals; Cell Membrane; Electric Conductivity; Guanidines; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Pyridines; Rabbits; Sarcolemma; Vasodilator Agents | 2000 |